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c(Hp~~soN OF DIPYRIDAMOLE-THALLIU SCINTICRAPHY AND 
AMBULATORY ECG MONITORING IN THE PRE-OPERATIVE ASSESSMENT 
OF CARDIAC RISK FOR VASCULAR SURGERY 
Stephen A. Abraham, N. Anthony Coles, Christopher h. 
aley, Charles A. Boucher, H. William Strauss, Kim A. 
Eagle. Hassachuset t s General Hospit al , Boston, MA 
We performed dipyridamole-thallium scintigraphy (DTS) and 
ambulatory ECG monitoring (AM, averaging 22 hrs) in 49 Prs 
prior to aortic (n=31), peripheral vascular (a-15) or non- 
vascular (n-2) surgery. Pts were judged to have an inter- 
mediate pre-test cardiac risk on the basis of possessing I 
or 2 of the following risk factors: history of angina 
(34X), prior MI (46X), or MF (a%), Q vaves on ECG (30X), 
diabetes (22%) or ventricular arrhythmias (4%) requiring 
therapy, end age > 70 yr (40%). 25148 (52%) of Pts demon- 
strated teversiblg abnormalities on DTS; 13/48 (27%) de- 
veloped iechemic ECG changes on AM; 7 (15X) Pts either 
suffered a pertoperative cardiac event, or were subse- 
quently found Lo have left main (tM) or 3 vessel (3V) 
coronary attery disease. DTS identified all 7; AM idenri- 
fied 4 of the 7 including both Pts who developed unstable 
angina (UA) and re- 
Total quired urgent CABG; 
25 AM failed to ldenti- 
DTS fy one Pe who sus- tained a poetop HI 
TOT 
of the 2 methods is shown. 
23 and 2 Pts shown to 
have LM or 3V. 
48 Relative concordance 
Conclusions: In this small cohort DTS vas a very sensitive 
(100%) teat for evaluation of cardiac risk but its speci- 
ficity (56%) was relatively low. AM was more specific 
(86%) but failed to identify several Pts at high risk 
(sens of 57%). 
EX-VIVO AND EARLY CLINICAL RESULTS USING A 
NEW PULLBACK ATHERECTOMY CATHETER (PAC) 
Tim A. Fischell, Robert E. Fischell, Robert 1. White, Robert 
Chapolini, Lewis Wexler. Stanford University Medical Center, 
Stanfotd, CA & Yale University School of Medicine, New Haven, CT. 
In order to evaluate the feasibility of performing definitive atheroma 
removal using a novel retrograde cutting (Pullback) atherectomy 
catheter, pullback atherectomy (PA) was performed in 14 severely 
diseased cadavcric superficial femoral atteries and in 4 patients with 
peripheral vascular disease. The device consists of a flexible outer 
“closing catheter,” and an inner “cut-collect” catheter which is rotated 
(2000 rpm) by a hand-held motor drive unit. A circumferential arc of 
uhcrotnatous tnatcsial is cut, and collected within a’%ollection chamber” 
with each pass. Expetimatts were performed using (non-fued) cadaver 
arteries either mounted in a perfusion/mounting chamber (n=l 1) or left 
in-situ (n=3). In general, a single cut was made with sequentially 
larger atherectomy catheters (2.5-3.5 mm diameter devices). The results 
were cvalua?ed by angiography and by light microscopy. lo/14 
experiments were performed in totally occluded vessels. Tissue was 
excised in 14/14 experiments and 5353 passes. The mean stenosis was 
improved from 95f3% prior to PA to 19&!5% after pullback 
athenctomy. The device was recently used succcssrUlly in four patients 
with severe stenoses of the supetficial femoral artety. “Stand alone” PA 
was pcrfonnd in 214 cases with adjunctive balloon angioplasty in the 
other two cases. Clinical and angiographic success, without vessel 
perforation or cmbolic complications was achieved in all cases. A 
multicenter clinical trial of pullback atherectomy for the treatment of 
peliphcralvasculardiseclseiinprognss. 
Conclusions: 1) Retrograde atherectomy with the Pullback 
Athcrcctomy Catheter (PAC) is a feasible meani of performing 
definitive atbercctomy. 2) Further clinical experience will be required 
before the utility of such a device is adequately d&ted. 
INTRAVASCULAR ULTRASOUND OF RENAL ARTERIES IN PATIENTS 
UNDERGOING PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; 
FEASIBILITY, SAFETY AND INITIAL FINDINGS, INCLUDING 3 
DIMENSIONAL RECONSTRUCTION OF RENAL ARTERIES 
Kenneth s, Douglaa W. Loaordo, Michael 
Harding, Ann Pieczek, James Waters3 Jeffrey M. Janer, 
Tufts Medical School,St.Elizabeth's Hospital,Bostvn, MA 
The repotted high incidence of restenosis complicating 
renal artery angioplaaty (PTRA), as well as inherent 
difficulties in balloon siting, underscores need for 
refinements in technique and aaaeasment of results. We 
employed intravascular ultrasound (IWS) as an adjunct 
to contrast angiography(Angio) in 5 consecutive pta 
(4F/ 1M: mean age=64y, range 29-79) undergoing PTRA. 
Stenoaes (ostial-2, proximal-2, and mid-vessel-l) wese 
due to atherosclerosis (ATH) in 4 and fibromuscular 
dysplasia (FMD) in 1. Balloons (diameter 4.5 to 6.0 
xmn,mean=5.3) and PWS (4.7 fr, 20 mHz) were introduced 
via 8 fr guides. PTRA waa successful with no 
complications in 5/S (100%) cases: %stenosis by Angie 
was 91f3 pre- and 29f2 post-PTRA. Systolic BP declined 
from 189f6 pre- to 146fS(p=.Ol) post-PTRA. Mean 
creatinine was 2.2 pre- and 2.4 post-PTRA (p=NS). XWS 
disclosed plaque-cracks at interventional sites in 4/4 
(100%) ATH cases, but not in FMD case. Lumina?. 
dimensions were easily measured for normal and 
interventional sites in S/5 (100%). In one ATH pt, 
IWS findings of residual luminal compromise not 
evident on Angio prompted dilatation with larger 
balloon and improved reault. In FMD pt, 3-dimensional 
reconstruction of IWS images into a profile familiar 
to the angiographec demol;strated circumferential ridges 
consistent wit11 Angio findings. This preliminary 
experience demonstrates that IWS during PTFtA 1) is 
feasible: 2) czn be performed without complications; 3) 
may help determine optimal device size and assess 
results. Further experience with thia new modality may 
xeduce contrast requirements during PTRA. 
INEO ATHEROSCLEROTIC PLAOUE ABLATION 0 AIJTOFLUORES- 
CENCE SPECTFIOSCOPY IN VITRO US1 
Andreas J. Morguet, Bernd Abel, Horst Hippler, Beate Ktir- 
ber, Heinrich Kreuzer, Volker Wiegand, Georg August Uni- 
verstity, GGttingen, West Germany 
To reduce the risk of vessel perforation during angio- 
plasty with a dye or a Ho:YAG laser, an additional He-Cd 
laser has already been applied to induce tissue fluores- 
cence for spectroscopy. This in vitro study was performed 
to find out whether the ultraviolet emission of a single 
excimer laser would be appropriate to combine plaque abla- 
tion and autofluorescence excitation. 
The beam of a XeCl excimer laser (308 nml was coupled to a 
600 Mm silica fiber through the central borehole of a con- 
cave mirror. Each laser pulse (14 - 28 mJ/mmz) ablated 
tissue and simultaneously induced autofluorescence whose 
light emanated retrogradely from the fiber and was collec- 
ted by the concave mirror for spectroscopy (320 - 650 nm). 
Samples of human aorta were studied in air, saline, and 
blood. Two spectral scores (I, II) based on 3 intensity 
ratios varied within the following ranges for normal media 
(NM), lipid plaques (LPI, and calcified plaques (CP) : . . 
kM 
I Air (I) 1 Saline (II) Blood (II) 
(n = 26) I 2 . 6 - 7 3. 
I 
I 7.9 - 16.4 7.1 - 11.9 
LP (n = 26) 9.z - 18.3 
I 
3.9 - 6.1 4.0 - 6.6 
CP (n = 27) 20.2 - 36.6 4.5 - 8.2 15.9 - 61.7 
As verified histologically, the spectra of NM, LP, and CP 
could clearly be differentiated qualitatively and quanti- 
tatively in air and in blood. Only the spectrum of CP 
proved to depend considerably on the surrounding medium. 
In saline, there was no clearcut spectroscopic difference 
between LP and CP, but NM and atherosclerotic material 
could still be well discriminated. 
In conclusion, using a XeCl excimer laser for combined 
plaque ablation and tissue fluorescence excitation, spec- 
troscopy can be performed in vitro without a second laser. 
